BioCentury | Nov 16, 2018
Tools & Techniques

Benchtop manufacturing gets smaller

Publisher’s note: This story originally ran in the Nov. 15, 2018 issue of BioCentury Innovations , a comprehensive source of developments in translational research with knowledgeable perspectives on the key innovations, trends and opportunities in early...
BC Innovations | Nov 15, 2018
Tools & Techniques

Benchtop manufacturing gets smaller

MIT scientists continue to break new ground in benchtop manufacturing systems for biologics. Published in Nature Biotechnology last month, the latest advance from the institute centered on an automated, closed system capable of producing clinical-grade...
BC Week In Review | Aug 22, 2016
Company News

Dyadic International, Sanofi, EnGen Bio deal

Dyadic said Sanofi’s Sanofi Pasteur S.A. vaccines unit will terminate a 2011 collaboration with Dyadic and EnGen to develop Dyadic’s C1 fungal expression technology for vaccine indications. The termination is effective Oct. 5. In 2010,...
BC Week In Review | Dec 7, 2015
Company News

Dyadic International, DuPont deal

Dyadic will sell its industrial technology business to DuPont’s industrial biosciences division for $75 million in cash. The sale includes substantially all of Dyadic’s enzyme and technology assets, including its C1 fungal expression technology platform....
BC Week In Review | Mar 16, 2015
Financial News

Dyadic International Inc completes private placement of subordinated notes

Dyadic International Inc . (OTCQX:DYAI), Jupiter, Fla.   Business: Genomics, Supply/Service, Biomanufacturing   Date completed: 2015-03-09   Type: Private placement of subordinated notes   Raised: $2 million   Investor: Existing investor   Note: The secured promissory...
BC Week In Review | Jan 12, 2015
Financial News

Dyadic International financial update

Dyadic International Inc. (OTCQX:DYAI), Jupiter, Fla.   Business: Genomics, Supply/Service, Biomanufacturing   Date announced: 2015-01-05   Note: Dyadic extended by one year to Jan. 1, 2016, the maturity date of a $1.4 million 9.5% note....
BC Week In Review | Nov 17, 2014
Financial News

Dyadic International financial update

Dyadic International Inc. (OTCQX:DYAI), Jupiter, Fla.   Business: Genomics, Supply/Service, Biomanufacturing   Date announced: 2014-10-30   Note: Dyadic extended to Jan. 1, 2016 the maturity date of $6.7 million in 2010 and 2011 8% convertible...
BC Week In Review | Oct 20, 2014
Financial News

Dyadic International financial update

Dyadic International Inc. (OTCQX:DYAI), Jupiter, Fla.   Business: Genomics, Supply/Service, Biomanufacturing   Date announced: 2014-10-10   Note: Dyadic withdrew its Form 10 filing with the SEC to avoid it becoming effective prior to completing the...
BC Week In Review | Sep 1, 2014
Financial News

Dyadic International financial update

Dyadic International Inc. (OTCQX:DYAI), Jupiter, Fla.   Business: Genomics, Supply/Service, Biomanufacturing   Date announced: 2014-08-15   Note: Dyadic filed a Form 10 with the SEC to become a publicly reporting company. At June 30, the...
BC Week In Review | Mar 17, 2014
Financial News

Dyadic International financial update

Dyadic began trading on OTCQX under the ticker "DYAI." Previously, the company traded on the Pink Sheets. Dyadic International Inc. (OTCQX:DYAI), Jupiter, Fla.   Business: Genomics, Supply/Service, Biomanufacturing   Date announced: 3/11/14  ...
Items per page:
1 - 10 of 31
BioCentury | Nov 16, 2018
Tools & Techniques

Benchtop manufacturing gets smaller

Publisher’s note: This story originally ran in the Nov. 15, 2018 issue of BioCentury Innovations , a comprehensive source of developments in translational research with knowledgeable perspectives on the key innovations, trends and opportunities in early...
BC Innovations | Nov 15, 2018
Tools & Techniques

Benchtop manufacturing gets smaller

MIT scientists continue to break new ground in benchtop manufacturing systems for biologics. Published in Nature Biotechnology last month, the latest advance from the institute centered on an automated, closed system capable of producing clinical-grade...
BC Week In Review | Aug 22, 2016
Company News

Dyadic International, Sanofi, EnGen Bio deal

Dyadic said Sanofi’s Sanofi Pasteur S.A. vaccines unit will terminate a 2011 collaboration with Dyadic and EnGen to develop Dyadic’s C1 fungal expression technology for vaccine indications. The termination is effective Oct. 5. In 2010,...
BC Week In Review | Dec 7, 2015
Company News

Dyadic International, DuPont deal

Dyadic will sell its industrial technology business to DuPont’s industrial biosciences division for $75 million in cash. The sale includes substantially all of Dyadic’s enzyme and technology assets, including its C1 fungal expression technology platform....
BC Week In Review | Mar 16, 2015
Financial News

Dyadic International Inc completes private placement of subordinated notes

Dyadic International Inc . (OTCQX:DYAI), Jupiter, Fla.   Business: Genomics, Supply/Service, Biomanufacturing   Date completed: 2015-03-09   Type: Private placement of subordinated notes   Raised: $2 million   Investor: Existing investor   Note: The secured promissory...
BC Week In Review | Jan 12, 2015
Financial News

Dyadic International financial update

Dyadic International Inc. (OTCQX:DYAI), Jupiter, Fla.   Business: Genomics, Supply/Service, Biomanufacturing   Date announced: 2015-01-05   Note: Dyadic extended by one year to Jan. 1, 2016, the maturity date of a $1.4 million 9.5% note....
BC Week In Review | Nov 17, 2014
Financial News

Dyadic International financial update

Dyadic International Inc. (OTCQX:DYAI), Jupiter, Fla.   Business: Genomics, Supply/Service, Biomanufacturing   Date announced: 2014-10-30   Note: Dyadic extended to Jan. 1, 2016 the maturity date of $6.7 million in 2010 and 2011 8% convertible...
BC Week In Review | Oct 20, 2014
Financial News

Dyadic International financial update

Dyadic International Inc. (OTCQX:DYAI), Jupiter, Fla.   Business: Genomics, Supply/Service, Biomanufacturing   Date announced: 2014-10-10   Note: Dyadic withdrew its Form 10 filing with the SEC to avoid it becoming effective prior to completing the...
BC Week In Review | Sep 1, 2014
Financial News

Dyadic International financial update

Dyadic International Inc. (OTCQX:DYAI), Jupiter, Fla.   Business: Genomics, Supply/Service, Biomanufacturing   Date announced: 2014-08-15   Note: Dyadic filed a Form 10 with the SEC to become a publicly reporting company. At June 30, the...
BC Week In Review | Mar 17, 2014
Financial News

Dyadic International financial update

Dyadic began trading on OTCQX under the ticker "DYAI." Previously, the company traded on the Pink Sheets. Dyadic International Inc. (OTCQX:DYAI), Jupiter, Fla.   Business: Genomics, Supply/Service, Biomanufacturing   Date announced: 3/11/14  ...
Items per page:
1 - 10 of 31